Uncategorized
NICE gives preliminary recommendation to Ozurdex for DME
The National Institute for Health and Care Excellence has recommended Allergan’s Ozurdex intravitreal dexamethasone implant for the treatment of diabetic macular edema in preliminary technology appraisal guidance, according to an agency release.The organization limited its recommendation to use in aphakic eyes in patients whose diabetic macular edema does not respond to non-corticosteroid treatment or for whom non-corticosteroid treatment is not suitable.